Jesus Moreno
Payments from drug & device makers
Across 190 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$712
- AstraZeneca$602
- GSK$510
- Regeneron Healthcare Solutions, Inc.$310
- Grifols USA, LLC$268
- ANI Pharmaceuticals, Inc.$237
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,49498%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $712 |
| AstraZeneca | 26 | $602 |
| GSK | 27 | $510 |
| Regeneron Healthcare Solutions, Inc. | 8 | $310 |
| Grifols USA, LLC | 12 | $268 |
| ANI Pharmaceuticals, Inc. | 7 | $237 |
| Boehringer Ingelheim | 8 | $203 |
| United Therapeutics Corporation | 8 | $198 |
| Viiv Healthcare Company | 3 | $176 |
| Actelion Pharmaceuticals US, Inc. | 3 | $142 |
| Sanofi | 5 | $135 |
| Harmony Biosciences LLC | 6 | $133 |
| Baxter Healthcare | 7 | $133 |
| Amgen | 7 | $117 |
| Philips North America LLC | 4 | $113 |
| Jazz Pharmaceuticals Inc. | 3 | $91 |
| Mallinckrodt Hospital Products Inc. | 4 | $87 |
| Phadia US Inc. | 4 | $68 |
| Gilead | 2 | $47 |
| Mylan Specialty L.p. | 2 | $43 |
| Novartis | 2 | $42 |
| Electromed, Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Theratechnologies Inc. | 1 | $30 |
| Merck | 1 | $29 |
| Bayer | 1 | $28 |
| Pharming Healthcare, Inc. | 1 | $23 |
| Pfizer | 1 | $23 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,592 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 39 | $300 |
| Omeprazole | 11 | $199 |
| Lisinopril | 23 | $180 |
| Rosuvastatin Calcium | 15 | $139 |
| Amlodipine Besylate | 18 | $124 |
| Gabapentin | 11 | $118 |
| Simvastatin | 12 | $109 |
| Levothyroxine Sodium | 14 | $105 |
| Montelukast Sodium | 16 | $104 |
| Metformin Hcl | 21 | $92 |
| Pantoprazole Sodium | 12 | $72 |
| Losartan Potassium | 11 | $66 |
| Hydrochlorothiazide | 11 | $59 |
| Cyclobenzaprine Hcl | 15 | $51 |
| Metoprolol Tartrate | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Tampa
- Lewis HarringtonTampa$954K
- Natasha WickTampa$126K
- Marie Labadie-DegennaroTampa$66K
- Polly BittleTampa$63K
- Katharine WilliamsTampa$47K
- Candace DeberryTampa$46K
- Bailey BlankenshipTampa$42K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.